CONMED (CNMD) Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 12 month target prices for CONMED's stock. Their CNMD share price forecasts range from $119.00 to $140.00. On average, they anticipate the company's share price to reach $130.40 in the next year. This suggests a possible upside of 2.8% from the stock's current price.
View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts.

CONMED's stock was trading at $88.64 at the beginning of the year. Since then, CNMD shares have increased by 43.1% and is now trading at $126.81.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CNMD earnings forecast.

CONMED Co. (NYSE:CNMD) released its earnings results on Wednesday, April, 26th. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.06. The company earned $295.47 million during the quarter, compared to analyst estimates of $266.66 million. CONMED had a positive trailing twelve-month return on equity of 11.38% and a negative net margin of 8.53%. The firm's revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period last year, the firm posted $0.70 earnings per share.

CONMED announced a quarterly dividend on Wednesday, May 24th. Stockholders of record on Thursday, June 15th will be given a dividend of $0.20 per share on Wednesday, July 5th. This represents a $0.80 annualized dividend and a dividend yield of 0.63%. The ex-dividend date is Wednesday, June 14th.
Read our dividend analysis for CNMD.

ETFs with the largest weight of CONMED (NYSE:CNMD) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), Small Cap US Equity Select ETF (RNSC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Xtrackers S&P SmallCap 600 ESG ETF (SMLE), BlackRock Future Health ETF (BMED), SPDR S&P SmallCap 600 ESG ETF (ESIX) and iShares S&P Small-Cap 600 Value ETF (IJS).

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.65%.
Read our dividend analysis for CNMD.

CONMED issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided EPS guidance of $3.30-$3.50 for the period, compared to the consensus earnings per share estimate of $3.32. The company issued revenue guidance of $1.21 billion-$1.25 billion, compared to the consensus revenue estimate of $1.19 billion.

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

CONMED's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.09%), Ameriprise Financial Inc. (4.42%), State Street Corp (3.81%), Champlain Investment Partners LLC (3.22%), Principal Financial Group Inc. (2.61%) and Macquarie Group Ltd. (2.50%). Insiders that own company stock include Brian Concannon, Daniel S Jonas, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III and Todd W Garner.
View institutional ownership trends.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNMD stock can currently be purchased for approximately $126.81.

CONMED (NYSE:CNMD) has a market capitalization of $3.88 billion and generates $1.10 billion in revenue each year. The company earns $-80,580,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis.

The company employs 4,100 workers across the globe.

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.